眼科イメージング機器のパイプライン - 開発段階、セグメント、地域と国、規制経路、主要企業（2024年版）

当レポートでは、眼科イメージング機器のパイプライン製品について調査分析し、さまざまな開発段階にある製品の比較分析や、進行中の臨床試験のデータを含む、包括的な情報を提供しています。

目次

第1章 目次

第2章 イントロダクション

第3章 開発中の製品

• 眼科イメージング機器 - パイプライン製品：開発段階別
• 眼科イメージング機器 - パイプライン製品：地域別
• 眼科イメージング機器 - パイプライン製品：規制経路別
• 眼科イメージング機器 - パイプライン製品：推定承認日別

第4章 眼科イメージング機器 - 各社の開発中のパイプライン製品

• 眼科イメージング機器企業 - パイプライン製品：開発段階別
• 眼科イメージング機器 - パイプライン製品：開発段階別

第5章 眼科イメージング機器メーカーと製品の概要

• Advanced Medical Electronics Corp：企業の概要
  • Advanced Medical Electronics Corp：パイプライン製品と進行中の臨床試験の概要
• Ai-Ris LLC：企業の概要
  • Ai-Ris LLC：パイプライン製品と進行中の臨床試験の概要
• Al.chi.mi.a. Srl：企業の概要
  • Al.chi.mi.a. Srl：パイプライン製品と進行中の臨床試験の概要
• City University of Hong Kong：企業の概要
  • City University of Hong Kong：パイプライン製品と進行中の臨床試験の概要
• Columbia University：企業の概要
  • Columbia University：パイプライン製品と進行中の臨床試験の概要
• IDCP Scotland Ltd：企業の概要
  • IDCP Scotland Ltd：パイプライン製品と進行中の臨床試験の概要
• JuneBrain, LLC：企業の概要
  • JuneBrain, LLC：パイプライン製品と進行中の臨床試験の概要
• L.V. Prasad Eye Institute：企業の概要
  • L.V. Prasad Eye Institute：パイプライン製品と進行中の臨床試験の概要
• Leica Microsystems GmbH：企業の概要
  • Leica Microsystems GmbH：パイプライン製品と進行中の臨床試験の概要
• Novai Ltd：企業の概要
  • Novai Ltd：パイプライン製品と進行中の臨床試験の概要
• Physical Sciences Inc：企業の概要
  • Physical Sciences Inc：パイプライン製品と進行中の臨床試験の概要
• RetinaScope BV：企業の概要
  • RetinaScope BV：パイプライン製品と進行中の臨床試験の概要
• Singapore Eye Research Institute：企業の概要
  • Singapore Eye Research Institute：パイプライン製品と進行中の臨床試験の概要
• Spring Vision Ltd：企業の概要
  • Spring Vision Ltd：パイプライン製品と進行中の臨床試験の概要
• TeleMedC Pte Ltd：企業の概要
  • TeleMedC Pte Ltd：パイプライン製品と進行中の臨床試験の概要
• University of South Florida：企業の概要
  • University of South Florida：パイプライン製品と進行中の臨床試験の概要

第6章 眼科イメージング機器 - 近年の発展

• 2024年5月8日：ContextVisionが2024年第1四半期中間レポートを発表
• 2024年5月7日：Optomedが2024年1月～3月の中間レポートを発表
• 2024年4月15日：Bausch + Lombは5月1日に2024年第1四半期の業績を発表する予定
• 2024年4月12日：ContextVisionが2023年度の年次レポートを発表
• 2024年3月1日：Molecular Partnersが電話会議を開催し、2023年第4四半期と通期の業績について議論し、今後の投資家向けプレゼンテーションを発表
• 2024年2月15日：Gland Pharma第3四半期決算、純利益192億ルピー、売上1,545億ルピー
• 2024年2月15日：Optomedが2023年1月～12月の財務諸表速報を発表
• 2024年2月14日：Gland Pharma、2023年12月31日までの四半期と9ヶ月間の監査対象外財務結果を発表
• 2023年11月3日：Optomedが2023年1月～9月の中間レポートを発表
• 2023年10月26日：ContextVisionが第3四半期の業績を発表
• 2023年8月28日：ContextVisionがRichard Hallstromを最高財務責任者に任命
• 2023年8月24日：ContextVision、堅調な利益成長で第2四半期の好調な業績を発表
• 2023年8月3日：Juho HimbergがOptomedのCEOに任命される

第7章 付録

List of Tables

• Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development
• Ophthalmic Imaging Equipment - Pipeline Products by Territory
• Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path
• Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date
• Ophthalmic Imaging Equipment Companies - Pipeline Products by Stage of Development
• Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development
• Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview
• Visual Imaging System - Product Status
• Visual Imaging System - Product Description
• Ai-Ris LLC Pipeline Products & Ongoing Clinical Trials Overview
• Portable Retinal Imaging System - Product Status
• Portable Retinal Imaging System - Product Description
• Al.chi.mi.a. Srl Pipeline Products & Ongoing Clinical Trials Overview
• Vitreous Visualization Device - Product Status
• Vitreous Visualization Device - Product Description
• City University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview
• SLD-PAM System - Product Status
• SLD-PAM System - Product Description
• Columbia University Pipeline Products & Ongoing Clinical Trials Overview
• Smartphone Retinal Imaging Camera - Product Status
• Smartphone Retinal Imaging Camera - Product Description
• IDCP Scotland Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 3D Eye Scanner - Product Status
• 3D Eye Scanner - Product Description
• JuneBrain, LLC Pipeline Products & Ongoing Clinical Trials Overview
• Neuro-i SS-OCT - Product Status
• Neuro-i SS-OCT - Product Description
• L.V. Prasad Eye Institute Pipeline Products & Ongoing Clinical Trials Overview
• Pediatric Perimeter - Product Status
• Pediatric Perimeter - Product Description
• Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview
• Forveo - Product Status
• Forveo - Product Description
• Novai Ltd Pipeline Products & Ongoing Clinical Trials Overview
• AI System - Age-Related Macular Degeneration - Product Status
• AI System - Age-Related Macular Degeneration - Product Description
• Physical Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
• Ophthalmic Imaging Instrument - Product Status
• Ophthalmic Imaging Instrument - Product Description
• Optics Imaging System - Alzheimer's Disease - Product Status
• Optics Imaging System - Alzheimer's Disease - Product Description
• RetinaScope BV Pipeline Products & Ongoing Clinical Trials Overview
• 3D Eye Imaging Device - Product Status
• 3D Eye Imaging Device - Product Description
• Singapore Eye Research Institute Pipeline Products & Ongoing Clinical Trials Overview
• Non-Invasive Imaging Tool - Product Status
• Non-Invasive Imaging Tool - Product Description
• Spring Vision Ltd Pipeline Products & Ongoing Clinical Trials Overview
• iCapture 45 - Product Status
• iCapture 45 - Product Description
• Next-Generation iCapture 45 - Product Status
• Next-Generation iCapture 45 - Product Description
• TeleMedC Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
• EyeScan R2 - Product Status
• EyeScan R2 - Product Description
• University of South Florida Pipeline Products & Ongoing Clinical Trials Overview
• Ophthalmic Imaging System - Product Status
• Ophthalmic Imaging System - Product Description
• Glossary

List of Figures

• Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development
• Ophthalmic Imaging Equipment - Pipeline Products by Territory
• Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path
• Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date

GlobalData's Medical Devices sector report, "Ophthalmic Imaging Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Ophthalmic Imaging Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Ophthalmic Imaging equipment is used to create images to aid in the diagnosis and treatment of eye diseases.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Ophthalmic Imaging Equipment under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Ophthalmic Imaging Equipment and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Ophthalmic Imaging Equipment under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Ophthalmic Imaging Equipment Overview

3 Products under Development

• 3.1 Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development
• 3.2 Ophthalmic Imaging Equipment - Pipeline Products by Territory
• 3.3 Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path
• 3.4 Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date

4 Ophthalmic Imaging Equipment - Pipeline Products under Development by Companies

• 4.1 Ophthalmic Imaging Equipment Companies - Pipeline Products by Stage of Development
• 4.2 Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development

5 Ophthalmic Imaging Equipment Companies and Product Overview

• 5.1 Advanced Medical Electronics Corp Company Overview
  • 5.1.1 Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Ai-Ris LLC Company Overview
  • 5.2.1 Ai-Ris LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Al.chi.mi.a. Srl Company Overview
  • 5.3.1 Al.chi.mi.a. Srl Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 City University of Hong Kong Company Overview
  • 5.4.1 City University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 Columbia University Company Overview
  • 5.5.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 IDCP Scotland Ltd Company Overview
  • 5.6.1 IDCP Scotland Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 JuneBrain, LLC Company Overview
  • 5.7.1 JuneBrain, LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 L.V. Prasad Eye Institute Company Overview
  • 5.8.1 L.V. Prasad Eye Institute Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Leica Microsystems GmbH Company Overview
  • 5.9.1 Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 Novai Ltd Company Overview
  • 5.10.1 Novai Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 Physical Sciences Inc Company Overview
  • 5.11.1 Physical Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 RetinaScope BV Company Overview
  • 5.12.1 RetinaScope BV Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 Singapore Eye Research Institute Company Overview
  • 5.13.1 Singapore Eye Research Institute Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 Spring Vision Ltd Company Overview
  • 5.14.1 Spring Vision Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 TeleMedC Pte Ltd Company Overview
  • 5.15.1 TeleMedC Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 University of South Florida Company Overview
  • 5.16.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview

6 Ophthalmic Imaging Equipment- Recent Developments

• 6.1 May 08, 2024: ContextVision Releases Q1 Interim Report 2024
• 6.2 May 07, 2024: Optomed Announces Interim Report, January - March 2024
• 6.3 Apr 15, 2024: Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1
• 6.4 Apr 12, 2024: ContextVision Releases Annual Report for Fiscal Year 2023
• 6.5 Mar 01, 2024: Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentations
• 6.6 Feb 15, 2024: Gland Pharma Q3 Results: Net porfit at Rs 192 cr, Revenue at Rs 1545 cr
• 6.7 Feb 15, 2024: Optomed Announces Financial Statements Bulletin, January - December 2023
• 6.8 Feb 14, 2024: Gland Pharma Announces Unaudited Financial Results for Quarter and Nine Months Ended December 31, 2023
• 6.9 Nov 03, 2023: Optomed Announces Interim Report, January - September 2023
• 6.10 Oct 26, 2023: ContextVision Reports Q3 Results
• 6.11 Aug 28, 2023: ContextVision Appoints Richard Hallstrom as Chief Financial Officer
• 6.12 Aug 24, 2023: ContextVision Announces Strong Second Quarter With Solid Margin Growth
• 6.13 Aug 03, 2023: Juho Himberg has been appointed CEO of Optomed

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer